[PDF][PDF] Platelet sequestration in man. II. Immunological and clinical studies
RH Aster, JH Jandl - The Journal of Clinical Investigation, 1964 - Am Soc Clin Investig
RH Aster, JH Jandl
The Journal of Clinical Investigation, 1964•Am Soc Clin InvestigMethods Preparation and transfusion of Cr51-! abeled" citrate platelets" and determination of
the percentage of platelet survival were as described in the preceding report (4). In"
extracting" Cr51-labeled platelets from blood samples taken from thrombocytopenic
persons, nonradioactive platelets were added to the platelet-rich plasma to facilitate
recovery of platelet Cr51. For isologous transfusions, only platelets from donors compatible
with the recipients' ABO and Rh blood types were used. Methods of scintillation scanning …
the percentage of platelet survival were as described in the preceding report (4). In"
extracting" Cr51-labeled platelets from blood samples taken from thrombocytopenic
persons, nonradioactive platelets were added to the platelet-rich plasma to facilitate
recovery of platelet Cr51. For isologous transfusions, only platelets from donors compatible
with the recipients' ABO and Rh blood types were used. Methods of scintillation scanning …
Methods
Preparation and transfusion of Cr51-! abeled" citrate platelets" and determination of the percentage of platelet survival were as described in the preceding report (4). In" extracting" Cr51-labeled platelets from blood samples taken from thrombocytopenic persons, nonradioactive platelets were added to the platelet-rich plasma to facilitate recovery of platelet Cr51. For isologous transfusions, only platelets from donors compatible with the recipients' ABO and Rh blood types were used. Methods of scintillation scanning over organs to evalu-ate sites of platelet sequestration have been described
The Journal of Clinical Investigation